Vaxxinity, Inc. (NASDAQ:VAXX – Get Rating) major shareholder United Biomedical Inc acquired 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 8th. The stock was acquired at an average price of $2.95 per share, with a total value of $29,500.00. Following the acquisition, the insider now owns 51,626,366 shares in […]
Brokerages expect Vaxxinity, Inc. (NASDAQ:VAXX – Get Rating) to report earnings of ($0.38) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Vaxxinity’s earnings, with estimates ranging from ($0.40) to ($0.35). The firm is expected to issue its next earnings results on Monday, January 1st. On average, […]
Vaxxinity (NASDAQ:VAXX – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday, Zacks.com reports. The brokerage currently has a $4.75 target price on the stock. Zacks Investment Research‘s price target points to a potential upside of 9.95% from the […]
Vaxxinity (NASDAQ:VAXX – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Vaxxinity Inc. is a biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Vaxxinity Inc. is based in DALLAS, Texas. “ […]